Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) is a publicly traded Healthcare sector company. As of May 21, 2026, BDRX trades at $3.11 with a market cap of $2.04M and a P/E ratio of 0.00. BDRX moved +0.00% today. Year to date, BDRX is -75.22%; over the trailing twelve months it is -95.29%. Its 52-week range spans $2.86 to $544.50. Rallies surfaces BDRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Biodexa Plans 1-for-10,000 Reverse Split Creating 373 Billion E Deferred Shares, Resets ADS Ratio: At its June 17 AGM, Biodexa proposes a 1-for-10,000 reverse share split, cutting issued ordinary shares from 373.06 billion to 37.31 million and creating 373.02 billion E deferred shares while preserving nominal capital. It will reset its ADS ratio from 500,000:1 to 50:1 effective June 18, keeping 746,113 ADSs outstanding.
| Metric | Value |
|---|---|
| Price | $3.11 |
| Market Cap | $2.04M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $544.50 |
| 52-Week Low | $2.86 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BDRX analyst coverage data. Average price target: $0.00.